Leadership changes, October 2026
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes
1,035
Appointments
576
Departures
68
Browse by role
October 2026
Get new CFO appointments the day the filing lands.
Filters
1,035 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | TruGolf Holdings, Inc. | Steven Passey | Vice President – Finance of the Company’s golf divisionVice President – Finance of the Company’s golf division | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | VEEA INC. | Helder Antunes | directordirector | Departed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | Victoria's Secret & Co. | Melinda McAfee | Chief Legal and Compliance OfficerCLO | Departed | Mar 31, 2027 | SEC 8-K |
| Oct 9, 2026 | Vogenx, Inc. | Richard Gorman | Chief Commercial OfficerChief Commercial Officer | Appointed | Oct 7, 2026 | SEC 8-K |
| Oct 9, 2026 | Vogenx, Inc. | Richard Gorman | DirectorDirector | Departed | Oct 12, 2026 | SEC 8-K |
| Oct 9, 2026 | Zedge, Inc. | Morris Berger | Chief Executive OfficerCEO | Appointed | Oct 1, 2026 | SEC 8-K |
| Oct 13, 2026 | ACCURAY INC | Mika Nishimura | Class II directorClass II director | Departed | n/a | SEC 8-K |
| Oct 13, 2026 | Alaunos Therapeutics, Inc. | Peter Harwin | directordirector | Appointed | Oct 13, 2026 | SEC 8-K |
| Oct 13, 2026 | Alaunos Therapeutics, Inc. | Robert W. Postma | directordirector | Departed | n/a | SEC 8-K |
| Oct 13, 2026 | Alaunos Therapeutics, Inc. | Michael A. Jerman | directordirector | Departed | n/a | SEC 8-K |
| Oct 13, 2026 | Alaunos Therapeutics, Inc. | Jaime W. Vieser | directordirector | Departed | n/a | SEC 8-K |
| Oct 13, 2026 | Avery Dennison Corp | Helen J. Sheirbon | President, Solutions GroupPresident | Appointed | Nov 3, 2026 | SEC 8-K |
| Oct 13, 2026 | Bausch & Lomb Corp | Brent Saunders | Chief Executive OfficerCEO | Departed | Oct 12, 2026 | SEC 8-K |
| Oct 13, 2026 | Bausch & Lomb Corp | Thomas J. Appio | interim Chief Executive OfficerCEO | Appointed | Oct 12, 2026 | SEC 8-K |
| Oct 13, 2026 | Bausch & Lomb Corp | Thomas J. Appio | interim Chief Executive OfficerCEO | Appointed | Oct 12, 2026 | SEC 8-K |
| Oct 13, 2026 | Brightline Interactive, Inc./NV | William Keneally | Chief Financial OfficerCFO | Appointed | Jun 1, 2026 | SEC 8-K |
| Oct 13, 2026 | CHARTER COMMUNICATIONS, INC. /MO/ | Adam Ray | Executive Vice President, Chief Commercial OfficerExecutive Vice President, Chief Commercial Officer | Departed | Oct 12, 2026 | SEC 8-K |
| Oct 13, 2026 | Corsair Gaming, Inc. | Sarah Kim | DirectorDirector | Departed | Dec 31, 2026 | SEC 8-K |
| Oct 13, 2026 | DANAHER CORP /DE/ | Daniel L. Comas | directordirector | Appointed | Oct 9, 2026 | SEC 8-K |
| Oct 13, 2026 | DANAHER CORP /DE/ | Robert M. Hershberg | directordirector | Appointed | Oct 9, 2026 | SEC 8-K |
- TruGolf Holdings, Inc.Appointed
Steven Passey Vice President – Finance of the Company’s golf division
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- VEEA INC.Departed
Helder Antunes director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- Victoria's Secret & Co.Departed
Melinda McAfee CLO
Filed Oct 9, 2026Effective Mar 31, 2027SEC 8-K
- Vogenx, Inc.Appointed
Richard Gorman Chief Commercial Officer
Filed Oct 9, 2026Effective Oct 7, 2026SEC 8-K
- Vogenx, Inc.Departed
Richard Gorman Director
Filed Oct 9, 2026Effective Oct 12, 2026SEC 8-K
- Zedge, Inc.Appointed
Morris Berger CEO
Filed Oct 9, 2026Effective Oct 1, 2026SEC 8-K
- ACCURAY INCDeparted
Mika Nishimura Class II director
Filed Oct 13, 2026SEC 8-K
- Alaunos Therapeutics, Inc.Appointed
Peter Harwin director
Filed Oct 13, 2026Effective Oct 13, 2026SEC 8-K
- Alaunos Therapeutics, Inc.Departed
Robert W. Postma director
Filed Oct 13, 2026SEC 8-K
- Alaunos Therapeutics, Inc.Departed
Michael A. Jerman director
Filed Oct 13, 2026SEC 8-K
- Alaunos Therapeutics, Inc.Departed
Jaime W. Vieser director
Filed Oct 13, 2026SEC 8-K
- Avery Dennison CorpAppointed
Helen J. Sheirbon President
Filed Oct 13, 2026Effective Nov 3, 2026SEC 8-K
- Bausch & Lomb CorpDeparted
Brent Saunders CEO
Filed Oct 13, 2026Effective Oct 12, 2026SEC 8-K
- Bausch & Lomb CorpAppointed
Thomas J. Appio CEO
Filed Oct 13, 2026Effective Oct 12, 2026SEC 8-K
- Bausch & Lomb CorpAppointed
Thomas J. Appio CEO
Filed Oct 13, 2026Effective Oct 12, 2026SEC 8-K
- Brightline Interactive, Inc./NVAppointed
William Keneally CFO
Filed Oct 13, 2026Effective Jun 1, 2026SEC 8-K
Adam Ray Executive Vice President, Chief Commercial Officer
Filed Oct 13, 2026Effective Oct 12, 2026SEC 8-K
- Corsair Gaming, Inc.Departed
Sarah Kim Director
Filed Oct 13, 2026Effective Dec 31, 2026SEC 8-K
- DANAHER CORP /DE/Appointed
Daniel L. Comas director
Filed Oct 13, 2026Effective Oct 9, 2026SEC 8-K
- DANAHER CORP /DE/Appointed
Robert M. Hershberg director
Filed Oct 13, 2026Effective Oct 9, 2026SEC 8-K